G6PC1 and triple-negative breast carcinoma: tRFLys−CTT−010 can promote triple-negative breast cancer (TNBC) progression by targeting the glucose-6-phosphatase catalytic (G6PC) subunit to regulate lactate production and glycogen consumption.155